Examples of using Vimpat in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
What is Vimpat?
Vimpat with alcohol.
How is Vimpat used?
Other information about Vimpat.
Vimpat is used as a long term treatment.
People also translate
If you stop using Vimpat.
Duration of the treatment with Vimpat Vimpat is used as a long term treatment.
BEFORE YOU TAKE VIMPAT.
Vimpat 200 mg are blue, oval film-coated tablets with a debossed‘SP' on one side and‘200' on the other side.
If your doctor decides to stop your treatment with Vimpat, he/she will decrease the dose step by step.
Vimpat 50 mg are pinkish, oval film-coated tablets with a debossed‘SP' on one side and‘50' on the other side.
Looking at the results of the three main studies taken together, 34% of the patients adding Vimpat 200 mg/ day and 40% of the patients adding Vimpat 400 mg/ day to their existing treatment achieved at least a 50% reduction in the number of seizures.
Vimpat 100 mg are dark yellow, oval film-coated tablets with a debossed‘SP' on one side and‘100' on the other side.
Duration of the treatment with Vimpat solution for infusion Your doctor will decide for how many days you will receive the infusions.
What Vimpat looks like and contents of the pack Vimpat 50 mg are pinkish, oval film-coated tablets with a debossed‘ SP' on one side and‘ 50' on the other side.
If you stop using Vimpat If your doctor decides to stop your treatment with Vimpat, he/she will decrease the dose step by step.
What Vimpat looks like and contents of the pack Vimpat 15 mg/ml syrup is a clear solution, slightly yellow to yellow-brown in colour.
Your doctor may decide to initiate Vimpat treatment with a single loading dose of 200 mg followed approximately 12 hours later by initiation of a maintenance dose regimen.
Vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent(16-18 years) patients with epilepsy.
In January 2019, Vimpat®(lacosamide) was approved in Japan for the treatment of partial onset seizures in children 4 years of age and older.
Vimpat solution for infusion was found to be physically compatible and chemically stable when mixed with the following diluents for at least 24 hours and stored in glass or PVC bags at temperatures up to 25°C.
Clinical experience The efficacy of Vimpat as adjunctive therapy at recommended doses(200 mg/ day, 400 mg/ day) was established in 3 multicenter, randomized, placebo-controlled clinical trials with a 12-week maintenance period.
Vimpat must not be used in people who are hypersensitive(allergic) to lacosamide or any of the other ingredients, or who have second or third degree AV block a type of heart rhythm disorder.
Do NOT take Vimpat• if you are allergic(hypersensitive) to lacosamide, or to peanuts or soya or any of the other ingredients of Vimpat listed in Section 6.
Vimpat solution for infusion can be administered intravenously without further dilution or can be diluted with sodium chloride 9 mg/ml(0.9%) solution for injection, glucose 50 mg/ml(5%) solution for injection or lactated Ringer's solution for injection.
Vimpat is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain partial onset seizure with or without secondary generalisation.
R& D update: Vimpat® with positive phase 3 results in PGTCS; four new phase 3 programs started: bimekizumab in psoriatic arthritis and axial spondyloarthritis; padsevonil in in drug-resistant focal epilepsy; rozanolixizumab in myasthenia gravis.
Vimpat 600 mg/day was also shown to be effective in controlled adjunctive therapy trials, although the efficacy was similar to 400 mg/day and patients were less likely to tolerate this dose because of CNS- and gastrointestinal-related adverse reactions.